
AI "Virtual Biotech" Could Save 9 in 10 Failed Drugs
Stanford researchers built an AI system that mimics a drug company, complete with a virtual chief scientist coordinating specialized AI agents. This breakthrough could rescue promising treatments that currently fail in clinical trials.





%2Ffile%2Fauthors%2F18017915061942152207.jpg)






